MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-50-0079077
Curis Pharma Private Limited
Curis Pharma Private Limited - chemicals in Lucknow, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹33.14 Lakh
▲ 37% YoY
Net loss · FY 2025
₹23,970
Net margin -0.7%
EBITDA · FY 2025
-₹22,806
EBITDA margin -0.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Curis Pharma Private Limited
Data last updated:
Curis Pharma Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the fine chemicals and other chemical products segment of the chemicals sector. It was incorporated on 25 July 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24299UP2019PTC119472. Its GSTIN is 09AAICC2978G1ZB (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anupam Kumar Pandey and Bharti Pandey.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 3 Madhupuram Coloney Bhithauli Khurd Stp Rd, Lucknow, Uttar Pradesh, India – 226020.
As per the financials filed for FY 2025, the company reported a revenue of ₹33.14 Lakh, a growth of 37% compared to the previous year. For the same year it recorded a net loss of ₹23,970 (net margin -0.7%) and EBITDA of -₹22,806 (EBITDA margin -0.7%). Revenue has grown at a compounded annual rate (CAGR) of 262% over three years.
Curis Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-50-0079077).
Company Details of Curis Pharma Private Limited
CIN U24299UP2019PTC119472
Registration Number 119472
Incorporation Date 25 July 2019
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-UP-50-0079077
Recognitions & Rankings of Curis Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No. 3 Madhupuram Coloney Bhithauli Khurd Stp Rd, Lucknow, Uttar Pradesh, India – 226020
- IndustryChemicals, Fine Chemicals And Other Chemical Products, Manufacturing, Other Chemical Product
Comprehensive company report
Curis Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Curis Pharma Private Limited
The main business activity of Curis Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Curis Pharma Private Limited FY 2025 filings available
Curis Pharma Private Limited reported revenue of ₹33.14 Lakh (up 37% YoY) for FY 2025.
Revenue · FY 2025
₹33.14 Lakh ▲ 37%
Net loss · FY 2025
₹23,970 margin -0.7%
EBITDA · FY 2025
-₹22,806 margin -0.7%
Compounded Annual Growth Rate (CAGR) of Curis Pharma Private Limited
Revenue CAGR growth
1 year
▲ 37%
3 years · compounded
▲ 262%
EBITDA CAGR growth
1 year
▼ 20%
3 years · compounded
▲ 51%
5 years · compounded
▲ 4%
Revenue has grown at a compounded annual rate (CAGR) of 262% over three years, including 37% growth in the latest year. EBITDA fell 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Curis Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹22,806 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹23,970 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Curis Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -0.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Curis Pharma are in the company report.
Premium access
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Curis Pharma Private Limited
Curis Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anupam Kumar Pandey Also directs: Nosam Labs Private Limited | Director | 25 Jul 2019 | 7 Years 2 Months | Current |
| Bharti Pandey | Additional Director | 23 Dec 2020 | 5 Years 9 Months | Current |
Peer Comparison of Curis Pharma Private Limited
Curis Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ojaskara Medicament Private Limited | ₹33.17 Lakh (FY 2024) | •••• | •••• | 51.0% | •••• | Rairangpur, Odisha, India |
| Sterling Star Beverages Private Limited | ₹33.15 Lakh (FY 2025) | •••• | •••• | -62.0% | •••• | Kolkata, West Bengal, India |
| Trinetra Dairy Products Private Limited | ₹33.15 Lakh (FY 2025) | •••• | •••• | 26.0% | •••• | Hyderabad, Telangana, India |
| Prakash Renewable Solutions India Private Limited | ₹33.15 Lakh (FY 2024) | •••• | •••• | -12.0% | •••• | New Delhi, Delhi, India |
| V S Electricals Private Limited | ₹33.15 Lakh (FY 2025) | •••• | •••• | -80.0% | •••• | Kolkata, West Bengal, India |
| Curis Pharma Private Limited this company | ₹33.14 Lakh (FY 2025) | •••• | •••• | 37.0% | •••• | Lucknow, Uttar Pradesh, India |
| Belhaven Impex Private Limited | ₹33.14 Lakh (FY 2025) | •••• | •••• | -52.0% | •••• | Thiruvananthapuram, Kerala, India |
| Shree Shyam Tradehouse Private Limited | ₹33.14 Lakh (FY 2025) | •••• | •••• | 0.0% | •••• | Bhilwara, Rajasthan, India |
| Avighna Vinimay Private Limited. | ₹33.14 Lakh (FY 2025) | •••• | •••• | 37.0% | •••• | Kolkata, West Bengal, India |
| Chamkaur Sahib Producer Company Limited | ₹33.14 Lakh (FY 2025) | •••• | •••• | 14.0% | •••• | Chamkaur Sahib, Punjab, India |
| Boomtech Solutions Private Limited | ₹33.14 Lakh (FY 2023) | •••• | •••• | 6818563.0% | •••• | Kolkata, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Curis Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Curis Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Curis Pharma Private Limited
Curis Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Curis Pharma Private Limited
Employment history and EPFO contributions of people linked to Curis Pharma.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Curis Pharma Private Limited
Curis Pharma Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Bharti Pandey was appointed as Additional Director on 23 Dec 2020.
AGM
Curis Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Curis Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh I.
Appointed
Bharti Pandey was appointed as Additional Director.
Ceased
Rekha Pandey ceased to be Director.
Appointed
Anupam Kumar Pandey was appointed as Director.
Incorporation
25 Jul 2019
Curis Pharma Private Limited was registered on 25 Jul 2019 with Roc Uttar Pradesh I & aged 7 years 2 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Curis Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Curis Pharma Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Curis Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Curis Pharma Private Limited
Curis Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAICC2978G1ZB | Uttar Pradesh | Active | 03 Aug 2019 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Curis Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Curis Pharma Private Limited
Curis Pharma is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in fine chemicals and other chemical products, within the chemicals industry. It was incorporated on 25 July 2019 (7+ years old) and is registered under CIN U24299UP2019PTC119472.
Curis Pharma reported revenue of ₹33.14 Lakh for FY 2025 (up 37% YoY).
Curis Pharma has 2 current directors:
- Anupam Kumar Pandey - Director
- Bharti Pandey - Additional Director
Curis Pharma reported a net loss of ₹23,970 (net margin -0.7%) and EBITDA of -₹22,806 (EBITDA margin -0.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Curis Pharma is 262% over three years. In the latest year (FY 2025) revenue rose 37%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Curis Pharma is 09AAICC2978G1ZB, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Curis Pharma is U24299UP2019PTC119472. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Curis Pharma was incorporated on 25 July 2019, making it 7+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Curis Pharma by revenue are Ojaskara Medicament Private Limited, Sterling Star Beverages Private Limited, Trinetra Dairy Products Private Limited, Prakash Renewable Solutions India Private Limited, V S Electricals Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Bharti Pandey was appointed as Additional Director on 23 Dec 2020. Rekha Pandey ceased to be Director on 07 Sep 2020. Anupam Kumar Pandey was appointed as Director on 25 Jul 2019.
Yes, Curis Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-50-0079077).